• No results found

Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion

N/A
N/A
Protected

Academic year: 2020

Share "Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion"

Copied!
8
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1 Demographic and clinical characteristics
Fig. 1 Change in retinal thickness after intravitreal bevacizumab. A 78-year-old patient presented with ischemic central retinal vein occlusion, which is shown by fluorescein angiography (a, b)
Table 2 Results for  nine cases of  ischemic central retinal vein occlusion
Table 3 Comparison between studies using bevacizumab for central retinal vein occlusion

References

Related documents

Tablet quality control tests such as weight variation, hardness, and friability, thickness, and drug release studies in different media were performed on

This analysis was used to investigate the presence of hydrogen bonds and intermolecular interactions in the crystal structure. The Hirshfeld surface analysis 26 was

Pertti Kauranen et al, Worked on Temperature optimization of a diesel engine using exhaust gas heat recovery and thermal energy storage (diesel engine with thermal energy storage)..

The proposed algorithm for synchronizing lane changes with SUMO yields a more realistic behavior of other traffic participants, and our extension of lane-change models yields

Statistical analysis of surgical cancelation data at the first level of our taxonomy of the surgical cancellation risk factors identified managerial factors as having